Cargando…
OR24-3 GPR31 Mediates the Proinflammatory Reponses in the Setting of Diabetic Inflammation
The pathogenesis of type 1 diabetes (T1D) involves the interaction of the immune system with pancreatic islets, featured by inflammation in both macrophages and β cells. The enzyme 12-lipoxygenase (12-LOX) is expressed in macrophages and β-cells, produces the eicosanoid 12(S)-HETE and promotes infla...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624811/ http://dx.doi.org/10.1210/jendso/bvac150.731 |
_version_ | 1784822327281713152 |
---|---|
author | Anderson, Ryan Avadhanam, Sriya Kulkarni, Abhishek Mirmira, Raghavendra Nelson, Jennifer Tersey, Sarah |
author_facet | Anderson, Ryan Avadhanam, Sriya Kulkarni, Abhishek Mirmira, Raghavendra Nelson, Jennifer Tersey, Sarah |
author_sort | Anderson, Ryan |
collection | PubMed |
description | The pathogenesis of type 1 diabetes (T1D) involves the interaction of the immune system with pancreatic islets, featured by inflammation in both macrophages and β cells. The enzyme 12-lipoxygenase (12-LOX) is expressed in macrophages and β-cells, produces the eicosanoid 12(S)-HETE and promotes inflammation. GPR31 has recently been identified as a 12(S)-HETE receptor. GPR31 protein levels increase in human islets after cytokine-induced inflammation. To elucidate the role of GPR31 in the 12-LOX pathway and during diabetic inflammation, we generated Gpr31b-/- mice on the C57BL/6J background. Gpr31-/- mice are viable, with normal body weight, glucose tolerance, and β-cell mass. Upon low dose streptozotocin treatment to induce β-cell inflammation, Gpr31b-/- mice remained normoglycemic unlike wildtype littermates and maintained near normal β-cell mass. To examine GPR31 in islet inflammation, RNA sequencing was performed on isolated mouse islets treated with a cytokine cocktail (IL-1β, IFN-γ, TNF-α). Both wildtype and Gpr31b-/- islets showed expected increases in Nos2 and Il1b after cytokine treatment. By contrast, Gpr31b-/- islets, showed changes in Gene Ontology pathways related to ER stress, oxidative stress, protein targeting, and MAPK activity compared to wildtype islets after cytokine treatment. To test a role for GPR31 in macrophage function, we first interrogated its role in the generation of proinflammatory macrophages upon polarization in vitro to the M1-like state using LPS and IFN-γ; under these conditions, we found no differences between Gpr31b-/- and wildtype macrophages, as assessed by flow cytometric analysis, suggesting that GPR31 does not play a role in macrophage polarization. Next, we tested if GPR31 is required for the ability of macrophages to migrate. To do this, bone marrow derived macrophages were isolated from Gpr31b-/- and wildtype littermates and in vitro migration assays were performed using Transwell chambers. We observed a significant decrease in migration of the Gpr31b-/- macrophages compared to wildtype macrophages. Taken together, our data support the concept that GPR31 promotes proinflammatory responses in both macrophages and pancreatic islets. Presentation: Monday, June 13, 2022 11:30 a.m. - 11:45 a.m. |
format | Online Article Text |
id | pubmed-9624811 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-96248112022-11-14 OR24-3 GPR31 Mediates the Proinflammatory Reponses in the Setting of Diabetic Inflammation Anderson, Ryan Avadhanam, Sriya Kulkarni, Abhishek Mirmira, Raghavendra Nelson, Jennifer Tersey, Sarah J Endocr Soc Diabetes & Glucose Metabolism The pathogenesis of type 1 diabetes (T1D) involves the interaction of the immune system with pancreatic islets, featured by inflammation in both macrophages and β cells. The enzyme 12-lipoxygenase (12-LOX) is expressed in macrophages and β-cells, produces the eicosanoid 12(S)-HETE and promotes inflammation. GPR31 has recently been identified as a 12(S)-HETE receptor. GPR31 protein levels increase in human islets after cytokine-induced inflammation. To elucidate the role of GPR31 in the 12-LOX pathway and during diabetic inflammation, we generated Gpr31b-/- mice on the C57BL/6J background. Gpr31-/- mice are viable, with normal body weight, glucose tolerance, and β-cell mass. Upon low dose streptozotocin treatment to induce β-cell inflammation, Gpr31b-/- mice remained normoglycemic unlike wildtype littermates and maintained near normal β-cell mass. To examine GPR31 in islet inflammation, RNA sequencing was performed on isolated mouse islets treated with a cytokine cocktail (IL-1β, IFN-γ, TNF-α). Both wildtype and Gpr31b-/- islets showed expected increases in Nos2 and Il1b after cytokine treatment. By contrast, Gpr31b-/- islets, showed changes in Gene Ontology pathways related to ER stress, oxidative stress, protein targeting, and MAPK activity compared to wildtype islets after cytokine treatment. To test a role for GPR31 in macrophage function, we first interrogated its role in the generation of proinflammatory macrophages upon polarization in vitro to the M1-like state using LPS and IFN-γ; under these conditions, we found no differences between Gpr31b-/- and wildtype macrophages, as assessed by flow cytometric analysis, suggesting that GPR31 does not play a role in macrophage polarization. Next, we tested if GPR31 is required for the ability of macrophages to migrate. To do this, bone marrow derived macrophages were isolated from Gpr31b-/- and wildtype littermates and in vitro migration assays were performed using Transwell chambers. We observed a significant decrease in migration of the Gpr31b-/- macrophages compared to wildtype macrophages. Taken together, our data support the concept that GPR31 promotes proinflammatory responses in both macrophages and pancreatic islets. Presentation: Monday, June 13, 2022 11:30 a.m. - 11:45 a.m. Oxford University Press 2022-11-01 /pmc/articles/PMC9624811/ http://dx.doi.org/10.1210/jendso/bvac150.731 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Diabetes & Glucose Metabolism Anderson, Ryan Avadhanam, Sriya Kulkarni, Abhishek Mirmira, Raghavendra Nelson, Jennifer Tersey, Sarah OR24-3 GPR31 Mediates the Proinflammatory Reponses in the Setting of Diabetic Inflammation |
title | OR24-3 GPR31 Mediates the Proinflammatory Reponses in the Setting of Diabetic Inflammation |
title_full | OR24-3 GPR31 Mediates the Proinflammatory Reponses in the Setting of Diabetic Inflammation |
title_fullStr | OR24-3 GPR31 Mediates the Proinflammatory Reponses in the Setting of Diabetic Inflammation |
title_full_unstemmed | OR24-3 GPR31 Mediates the Proinflammatory Reponses in the Setting of Diabetic Inflammation |
title_short | OR24-3 GPR31 Mediates the Proinflammatory Reponses in the Setting of Diabetic Inflammation |
title_sort | or24-3 gpr31 mediates the proinflammatory reponses in the setting of diabetic inflammation |
topic | Diabetes & Glucose Metabolism |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624811/ http://dx.doi.org/10.1210/jendso/bvac150.731 |
work_keys_str_mv | AT andersonryan or243gpr31mediatestheproinflammatoryreponsesinthesettingofdiabeticinflammation AT avadhanamsriya or243gpr31mediatestheproinflammatoryreponsesinthesettingofdiabeticinflammation AT kulkarniabhishek or243gpr31mediatestheproinflammatoryreponsesinthesettingofdiabeticinflammation AT mirmiraraghavendra or243gpr31mediatestheproinflammatoryreponsesinthesettingofdiabeticinflammation AT nelsonjennifer or243gpr31mediatestheproinflammatoryreponsesinthesettingofdiabeticinflammation AT terseysarah or243gpr31mediatestheproinflammatoryreponsesinthesettingofdiabeticinflammation |